Acute oral alkali citrate load in healthy humans--response of blood and urinary citrate, mineral metabolism, and factors related to stone formation
- PMID: 4049601
- DOI: 10.1007/BF00261817
Acute oral alkali citrate load in healthy humans--response of blood and urinary citrate, mineral metabolism, and factors related to stone formation
Abstract
In ten healthy volunteers (male/female = 5/5) the effects of two doses (2.5 and 5.0 g) of orally ingested alkali citrate (AC) on serum citrate, variables of mineral metabolism in serum, the urinary excretion of citrate, sodium and minerals were studied and compared with the effects of an oral vehicle load. Also, phosphate crystalluria and the supersaturation of several stone forming phases in urine were evaluated under all loads. The data allow to conclude that 1) the rise in serum citrate may result from citrate absorbed intestinally under AC; 2) systemic metabolic alkalosis is not detectable with the chosen AC doses but may be reflected by the more alkaline urinary pH and a higher citrate excretion; 3) mineral metabolism, serum ionized calcium, parathormone, calcitonin and urinary cyclic AMP included, are more or less stable under acute loads of AC; 4) postprandial phosphate crystalluria is more pronounced with increasing AC, but despite this the direct correlation with the supersaturation of hydroxyapatite is progressively weakened with both doses AC suggesting that the inhibitory effects of this drug may dominate over its effects upon initiation of precipitation.
Similar articles
-
Effects of acute oral sodium potassium citrate load in healthy males--outlook for treatment of patients with calcium-containing renal stones.Urol Int. 1987;42(2):81-8. doi: 10.1159/000281860. Urol Int. 1987. PMID: 3617247
-
Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine.Methods Find Exp Clin Pharmacol. 1997 Jul-Aug;19(6):417-27. Methods Find Exp Clin Pharmacol. 1997. PMID: 9385591 Clinical Trial.
-
Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.Urol Res. 1992;20(5):347-53. doi: 10.1007/BF00922747. Urol Res. 1992. PMID: 1455567
-
Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.Arch Ital Urol Androl. 2009 Sep;81(3):182-7. Arch Ital Urol Androl. 2009. PMID: 19911682 Review.
-
Urine citrate and renal stone disease.CMAJ. 1989 Aug 1;141(3):217-21. CMAJ. 1989. PMID: 2665909 Free PMC article. Review.
Cited by
-
Fasting gastrinemia and elevated supersaturation with hydroxyapatite of fasting urine--observations in renal calcium stone patients and controls.Urol Res. 1987;15(2):99-104. doi: 10.1007/BF00260941. Urol Res. 1987. PMID: 3035774
-
Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.Urol Res. 2005 May;33(2):116-24. doi: 10.1007/s00240-005-0466-6. Epub 2005 May 4. Urol Res. 2005. PMID: 15871014 Clinical Trial.
-
Urolithiasis--historical, comparative and pathophysiological aspects: a review.J R Soc Med. 1989 Nov;82(11):669-72. doi: 10.1177/014107688908201112. J R Soc Med. 1989. PMID: 2687468 Free PMC article. Review. No abstract available.
-
Urolithiasis research--where is it going?Urol Res. 1985;13(4):157-9. doi: 10.1007/BF00261816. Urol Res. 1985. PMID: 4049600 No abstract available.
-
Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.Urol Res. 1992;20(2):145-55. doi: 10.1007/BF00296527. Urol Res. 1992. PMID: 1553790
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical